NCT00481702

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

A Prospective, Multicenter, Open-Label, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-Abdominal Infections in Adults

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 300 (planned)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A multicenter study to evaluate the effectiveness of ertapenem compared to ceftriaxone/metronidazole in treating certain abdominal infections that require surgery in adult patients.

Conditions

• Intra-abdominal Infection

Interventions

Type	Name	Description
DRUG	Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks
DRUG	MK0826, /Duration of Treatment : 8 Weeks
DRUG	Comparator: metronidazole / Duration of Treatment: 8 Weeks

Timeline

• Start date: 2001-12-01
• Primary completion: 2003-06-01
• Completion: 2003-06-01
• First posted: 2007-06-04
• Last updated: 2017-02-20